News
Filter results
Announcements
Center for Development and Production of Highly Potent Drugs
TZF Polfa, a Polish pharmaceutical manufacturer, proudly presents its latest venture in Warsaw – the Center for Development and Production of Highly Potent Drugs, one of the most…
Read more
Announcements
Appointment of the President of Management Board of TZF Polfa S.A.
Following a formal selection process, the Supervisory Board has appointed Małgorzata Pajączek as President of the Management Board (CEO) of TZF Polfa, bringing to the company her extensive…
Read more
Announcements
Appointment of the new Management Board of TZF Polfa S.A.
As a result of the conducted proceedings, the Supervisory Board of TZF Polfa S.A. has appointed Katarzyna Piotrowska-Radziewicz and Ewelina Kabała to the Company’s Management Board, whose 11th…
Read more
Announcements
Selection procedure for the position of President of the Management Board
The Supervisory Board of Tarchomińskie Zakłady Farmaceutyczne “Polfa” S.A., with its registered office in Warsaw, hereby announces a selection procedure for the position of President of the Management…
Read more
Announcements
Selection procedure for the position of First Member of the Management Board
The Supervisory Board of Tarchomińskie Zakłady Farmaceutyczne “Polfa” S.A., with its registered office in Warsaw, hereby announces a selection procedure for the position of First Member of the…
Read more
Announcements
Selection procedure for the position of Second Member of the Management Board
The Supervisory Board of Tarchomińskie Zakłady Farmaceutyczne “Polfa” S.A., with its registered office in Warsaw, hereby announces a selection procedure for the position of Second Member of the…
Read more
Announcements
Success in the development of the medicinal product Dapagliflozinum 10 mg
We are pleased to announce that the newly developed medicinal product Dapagliflozinum, 10 mg, coated tablets, has successfully passed bioequivalence testing. The project is co-financed from the state…
Read more
Announcements
Distribution of PolhuminPen injectors
Please note that inquiries regarding the free distribution of PolhuminPen should be sent directly to: wstrzykiwacze@tzf.pl. For more information, please call: +48 (22) 510 80 01.
Read more